Osteopore ipo, page-15

I will honestly be be shocked if this baby doesn’t double within a few days of IPO
1) A phenomenal team steering the ship - Also being supported by a few heavy hitters such as Asia Cornerstone Asset Management
2) A track record of FDA approvals
3) Promising technology that will give them access to a 6.2B AUD market
4) It actually has decent revenue behind it...unlike the majority of these Pharma IPO’s as of late.